N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART

T Berg1, D Zdunek, J Stalke

  • 1Medizinisches Labor Dr. Berg, Berlin, Germany.

Insights

HIV patients on HAART show elevated NT-proBNP levels compared to blood donors, indicating potential cardiac strain. This finding supports increased cardiovascular event risk in HIV-infected individuals.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Biomarkers

Background:

  • Highly active anti-retroviral therapy (HAART) improves survival in HIV patients.
  • HIV-infected individuals face increased cardiovascular complications.
  • N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a cardiac function indicator.

Purpose of the Study:

  • To compare NT-proBNP levels in HIV patients on HAART versus healthy blood donors.
  • To investigate the relationship between NT-proBNP levels and cardiovascular risk factors in HIV patients.

Main Methods:

  • Analyzed NT-proBNP levels in 495 HIV patients on HAART and 1980 blood donors using an electrochemiluminescence immunoassay (ECLIA).
  • Compared NT-proBNP levels across different age groups and genders.
  • Assessed correlations with cardiovascular risk factors, including GFR and CRP.

Main Results:

  • HIV patients exhibited significantly higher NT-proBNP levels than age-matched blood donors across most age groups.
  • Elevated NT-proBNP was observed consistently across age and gender groups.
  • NT-proBNP levels did not correlate with most cardiovascular risk factors in HIV patients, except for CRP.
  • No evidence of cardiotoxicity from HAART or specific antiretroviral drugs was found.
  • High NT-proBNP levels were noted in Hepatitis C virus (HCV) patients treated with alpha-interferon.

Conclusions:

  • HIV patients on HAART have elevated NT-proBNP, suggesting increased cardiac strain.
  • Higher prevalence of cardiovascular and HIV-associated risk factors may contribute to elevated NT-proBNP.
  • Findings align with increased cardiovascular event incidence in HIV-infected individuals.
  • Further research is needed to link NT-proBNP levels to cardiovascular outcomes in HIV.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...